Erik Sims
Corporate Officer/Principal bei OCUPHIRE PHARMA, INC.
Profil
Erik Sims is currently working as the Senior Director-Finance at Ocuphire Pharma, Inc. He previously worked as the Assistant Controller at Gemphire Therapeutics, Inc. Mr. Sims holds an MBA from Walsh College and an undergraduate degree from the University of Michigan-Flint.
Aktive Positionen von Erik Sims
| Unternehmen | Position | Beginn |
|---|---|---|
| OCUPHIRE PHARMA, INC. | Corporate Officer/Principal | 01.06.2023 |
Ehemalige bekannte Positionen von Erik Sims
| Unternehmen | Position | Ende |
|---|---|---|
| NEUROBO PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ausbildung von Erik Sims
| Walsh College | Masters Business Admin |
| University of Michigan-Flint | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OCUPHIRE PHARMA, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI. | Health Technology |
